C-L9PXNADMED
NAD measurement, glutathione measurement, enzymatic assay
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-L9PX
C-L9PXC-L9PXNAD measurement, glutathione measurement, enzymatic assay
0-100 chain-logic scale · 15 dimensions · scored on public evidence
No company beliefs, mission, or scientific theories can be extracted from the provided Wayback snapshot text because the visible content is only an Internet Archive verification/interstitial page and does not show NADMED's actual website content.
SourceNo company beliefs, mission, or longevity theory are visible in the provided snapshot text; the visible content is only Wayback Machine navigation and crawl metadata, so no substantive company stance can be extracted from this capture excerpt.
SourceNo company belief, mission, or theory text is visible in the provided 2017-06-15 Wayback snapshot excerpt. The visible content is only the Internet Archive Wayback interface and capture metadata, so no company stance can be reliably extracted from this snapshot alone.
SourceThe company’s stated position is that NAD metabolites are fundamental regulators of cellular energy transfer, signaling, growth, and repair, and that disturbances in NAD balance are linked to metabolic, degenerative, and mitochondrial disease. It presents accurate measurement of NAD forms as clinically and scientifically important because NAD levels and ratios may reflect disease state, help explain individual variation in response to NAD-boosting interventions such as vitamin B3, and eventually guide treatment decisions.
SourceThe company presents the view that loss or disruption of NAD is a fundamental cause of age-related decline, and that restoring or supporting NAD can improve cellular energy, repair, and overall health. Its stance appears to frame aging and degenerative illness as problems that can be addressed upstream through NAD-focused medicine rather than only treating downstream symptoms.
SourceThe company’s stated position is that NAD metabolites are fundamental regulators of cellular energy transfer, growth, repair, and broader metabolic balance, and that disturbances in NAD levels or NAD redox balance are linked to metabolic, degenerative, and mitochondrial disease. It presents reliable, rapid measurement of NAD forms in blood and other common samples as necessary to understand disease, monitor physiology, and eventually guide individualized clinical decisions, including the use of NAD-boosting interventions.
SourceNo company beliefs, mission statement, or theory claims are visible in the provided 2014-01-02 Wayback snapshot text; the visible content is only Internet Archive wrapper and crawl metadata.
Source